Business Standard

Jenburkt Pharmaceuticals standalone net profit rises 53.90% in the December 2017 quarter

Image

Capital Market

Sales rise 23.93% to Rs 30.87 crore

Net profit of Jenburkt Pharmaceuticals rose 53.90% to Rs 4.54 crore in the quarter ended December 2017 as against Rs 2.95 crore during the previous quarter ended December 2016. Sales rose 23.93% to Rs 30.87 crore in the quarter ended December 2017 as against Rs 24.91 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales30.8724.91 24 OPM %20.9317.50 -PBDT7.044.93 43 PBT6.664.48 49 NP4.542.95 54

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 10 2018 | 1:31 PM IST

Explore News